Eclipse Regenesis, Inc.

Mountain View, CA

UEI
NNJ5XHMGNKS8
CAGE
84F74
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2495 Hospital Dr #300, Mountain View, CA 94040, USA
Founded
2017
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sbir phase II: endoluminal fixation of a distraction enterogenesis device 2232550 National Science Foundation $1,470,358
Intestinal lengthening via distraction enterogenesis for the treatment of short bowel syndrome R44DK127658 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $4,894,640
Sbir phase I: endoluminal fixation of a distraction enterogenesis device 2036538 Division of Industrial Innovation $256,000

Grant subawards

Prime recipient Prime award Amount Awarded
Research Institute At Nationwide Children's Hospital The specific milestone for this phase of the study is the completion of the initial safety data set of the first 10 human subjects (2 adults and 8 pediatric… P50FD007961 $50,000

Similar vendors

Vendor Location Primary NAICS
Aspero Medical, Inc. UEI TDG7FH5K6ZJ4 Westminster, CO 339112 Surgical and Medical Instrument Manufacturing
Medical Device R&D UEI PWMHH9QT8P93 San Francisco, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Deep Blue Medical Advances Inc. UEI Y27WEPKFPDV9 Durham, NC 339113 Surgical Appliance and Supplies Manufacturing
Averto Medical Inc. UEI QD1WD56LF265 Redwood City, CA 339112 Surgical and Medical Instrument Manufacturing
Mercator Medsystems, Inc. UEI KLANRKKPWQT4 San Leandro, CA 339112 Surgical and Medical Instrument Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Eclipse Regenesis, Inc. is a for-profit manufacturer of medical devices registered to do business with the federal government through SAM.gov since May 2018. The company develops innovative technologies to treat short bowel syndrome.

Eclipse Regenesis has received over $4.4 million in federal grants to support the development and testing of a distraction enterogenesis device to lengthen the intestine and restore natural nutrient absorption for short bowel syndrome patients. This includes a $970,484 National Science Foundation grant in 2023 to develop a minimally invasive delivery method, a $3.1 million National Institutes of Health grant in 2021 to conduct preclinical animal testing and a first-in-human clinical trial of the device, and a $256,000 National Science Foundation Small Business Innovation Research grant in 2020 to develop tissue anchors to fixate the device in the intestine. Eclipse Regenesis also received a $50,000 subaward from the University of California, San Francisco in support of medical device design and development services provided by Meraqi Medical.

Quick answers

Is Eclipse Regenesis, Inc. registered in SAM.gov?

Yes. Eclipse Regenesis, Inc.'s SAM.gov registration is active through June 1, 2027.

What is Eclipse Regenesis, Inc.'s CAGE code?

Eclipse Regenesis, Inc.'s CAGE code is 84F74, and its Unique Entity ID (UEI) is NNJ5XHMGNKS8.

What is Eclipse Regenesis, Inc.'s most recent federal award?

Eclipse Regenesis, Inc.'s most recent federal grant award is Sbir phase II: endoluminal fixation of a distraction enterogenesis device (2232550), from National Science Foundation, on May 1, 2023.

On GovTribe

See Eclipse Regenesis, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe